Trial · NCT01289821
Adverse events110
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 110
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypokalemia | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 6 | 53 | 9 |
| other | Hyponatremia | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 4 | 53 | 4 |
| other | Hypophosphatemia | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 14 | 53 | 35 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 6 | 53 | 10 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 10 | 53 | 15 |
| other | Chest wall pain | Musculoskeletal and connective tissue disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 3 |
| other | Musculoskeletal and connective tissue disorder - Other, specify | Musculoskeletal and connective tissue disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 4 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 5 | 53 | 6 |
| other | Dizziness | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 6 | 53 | 6 |
| other | Dysgeusia | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 16 | 53 | 18 |
| other | Dysesthesia | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 7 | 53 | 14 |
| other | Headache | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 8 | 53 | 15 |
| other | Lethargy | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 10 | 53 | 29 |
| other | Paresthesia | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 28 | 53 | 71 |
| other | Peripheral sensory neuropathy | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 24 | 53 | 47 |
| other | Somnolence | Nervous system disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 4 |
| other | Conjunctivitis | Eye disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 4 |
| other | Eye disorders - Other, specify | Eye disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 3 | 53 | 4 |
| other | Insomnia | Psychiatric disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 5 | 53 | 6 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6) | 5 | 53 | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01289821/events?page=3